Comparative study microporous cholestyramine analogue filicol treatment severe primary hypercholesterolemia Short- long-term results hypolipidemic effect gemfibrozil severe hypercholesterolemia Fifty patients primary hypercholesterolemia patients familial hypercholesterolemia stable low-density lipoprotein cholesterol levels mmol/L mg/dL SD mmol/L mg/dL hypolipidemic diet treatment weeks g/d filicol microporous cholestyramine analogue g/d gemfibrozil randomized clinical trial Tolerance good drugs Filicol gemfibrozil similar decrements total cholesterol low-density lipoprotein cholesterol apolipoprotein Close patients decreases low-density lipoprotein cholesterol levels drugs Gemfibrozil plasma high-density lipoprotein cholesterol apolipoprotein A-I levels triglyceride levels loss efficacy drug subsets patients good response rate therapy months study gemfibrozil beneficial effect aspects plasma lipid profile patients severe hypercholesterolemia clinical situation potential advantages standard doses anion-exchange resins 